Group 1 - The company held a shareholders' meeting on November 11, 2024, at its headquarters in Tianjin, with all board members present [1] - The meeting adopted a combination of on-site and online voting methods, presided over by the chairman, Yan Kaijing [1] - The attendance included 9 out of 9 current directors and 4 out of 5 current supervisors, with one supervisor absent due to work commitments [1] Group 2 - The proposal for the third quarter profit distribution for 2024 was approved during the meeting [2] - The voting for the proposal was a non-cumulative voting process, requiring a simple majority of the valid votes cast by attending shareholders [2] - The meeting was legally witnessed by lawyers from Inner Mongolia Jianzhong Law Firm, confirming that the meeting's procedures and voting results were valid and compliant with relevant laws and regulations [2]
天士力医药集团股份有限公司 2024年第三次临时股东大会决议公告